Ma X - Search Results

1

Improved retroviral vector design results in sustained expression after adult gene therapy in mucopolysaccharidosis I mice.

Herati RS, Ma X, Tittiger M, Ohlemiller KK, Kovacs A, Ponder KP. Herati RS, et al. Among authors: ma x. J Gene Med. 2008 Sep;10(9):972-82. doi: 10.1002/jgm.1229. J Gene Med. 2008. PMID: 18613275 Free PMC article.

2

Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig.

Ponder KP, Wang B, Wang P, Ma X, Herati R, Wang B, Cullen K, O'Donnell P, Ellinwood NM, Traas A, Primeau TM, Haskins ME. Ponder KP, et al. Among authors: ma x. Mol Ther. 2006 Jul;14(1):5-13. doi: 10.1016/j.ymthe.2006.03.015. Epub 2006 May 12. Mol Ther. 2006. PMID: 16698321 Free article.

3

Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice.

Chung S, Ma X, Liu Y, Lee D, Tittiger M, Ponder KP. Chung S, et al. Among authors: ma x. Mol Genet Metab. 2007 Feb;90(2):181-92. doi: 10.1016/j.ymgme.2006.08.001. Epub 2006 Sep 18. Mol Genet Metab. 2007. PMID: 16979922

4

Cutting edge: treatment of complement regulatory protein deficiency by retroviral in vivo gene therapy.

Spitzer D, Wu X, Ma X, Xu L, Ponder KP, Atkinson JP. Spitzer D, et al. Among authors: ma x. J Immunol. 2006 Oct 15;177(8):4953-6. doi: 10.4049/jimmunol.177.8.4953. J Immunol. 2006. PMID: 17015675

5

Improvements in mucopolysaccharidosis I mice after adult retroviral vector-mediated gene therapy with immunomodulation.

Ma X, Liu Y, Tittiger M, Hennig A, Kovacs A, Popelka S, Wang B, Herati R, Bigg M, Ponder KP. Ma X, et al. Mol Ther. 2007 May;15(5):889-902. doi: 10.1038/sj.mt.6300112. Epub 2007 Feb 20. Mol Ther. 2007. PMID: 17311010 Free article.

6

Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy.

Traas AM, Wang P, Ma X, Tittiger M, Schaller L, O'donnell P, Sleeper MM, Vite C, Herati R, Aguirre GD, Haskins M, Ponder KP. Traas AM, et al. Among authors: ma x. Mol Ther. 2007 Aug;15(8):1423-31. doi: 10.1038/sj.mt.6300201. Epub 2007 May 22. Mol Ther. 2007. PMID: 17519893 Free article.

7

High expression reduces an antibody response after neonatal gene therapy with B domain-deleted human factor VIII in mice.

Xu L, Mei M, Ma X, Ponder KP. Xu L, et al. Among authors: ma x. J Thromb Haemost. 2007 Sep;5(9):1805-12. doi: 10.1111/j.1538-7836.2007.02629.x. Epub 2007 May 21. J Thromb Haemost. 2007. PMID: 17596134 Free article.

8

Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice.

Ma X, Tittiger M, Knutsen RH, Kovacs A, Schaller L, Mecham RP, Ponder KP. Ma X, et al. Mol Genet Metab. 2008 Jul;94(3):298-304. doi: 10.1016/j.ymgme.2008.03.018. Epub 2008 May 13. Mol Genet Metab. 2008. PMID: 18479957 Free PMC article.

9

A self-inactivating gamma-retroviral vector reduces manifestations of mucopolysaccharidosis I in mice.

Metcalf JA, Ma X, Linders B, Wu S, Schambach A, Ohlemiller KK, Kovacs A, Bigg M, He L, Tollefsen DM, Ponder KP. Metcalf JA, et al. Among authors: ma x. Mol Ther. 2010 Feb;18(2):334-42. doi: 10.1038/mt.2009.236. Epub 2009 Oct 20. Mol Ther. 2010. PMID: 19844196 Free PMC article.

10

Neonatal intravenous injection of a gammaretroviral vector has a low incidence of tumor induction in mice.

Tittiger M, Ma X, Xu L, Ponder KP. Tittiger M, et al. Among authors: ma x. Hum Gene Ther. 2008 Nov;19(11):1317-23. doi: 10.1089/hum.2008.070. Hum Gene Ther. 2008. PMID: 19866493 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,974 results

Search Page

Filters